A citation-based method for searching scientific literature

Mariana L Oliveira, Padma Akkapeddi, Isabel Alcobia, Afonso R Almeida, Bruno A Cardoso, Rita Fragoso, Teresa L Serafim, João T Barata. Cell Signal 2017
Times Cited: 19







List of co-cited articles
215 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Andrew P Weng, Adolfo A Ferrando, Woojoong Lee, John P Morris, Lewis B Silverman, Cheryll Sanchez-Irizarry, Stephen C Blacklow, A Thomas Look, Jon C Aster. Science 2004
47

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.
Yu Liu, John Easton, Ying Shao, Jamie Maciaszek, Zhaoming Wang, Mark R Wilkinson, Kelly McCastlain, Michael Edmonson, Stanley B Pounds, Lei Shi,[...]. Nat Genet 2017
392
47

IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.
Ana Silva, Angelo B A Laranjeira, Leila R Martins, Bruno A Cardoso, Jocelyne Demengeot, J Andrés Yunes, Benedict Seddon, João T Barata. Cancer Res 2011
95
36

The genetics and mechanisms of T cell acute lymphoblastic leukaemia.
Laura Belver, Adolfo Ferrando. Nat Rev Cancer 2016
201
36

Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
Joao T Barata, Ana Silva, Joana G Brandao, Lee M Nadler, Angelo A Cardoso, Vassiliki A Boussiotis. J Exp Med 2004
195
36

Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.
Priscila P Zenatti, Daniel Ribeiro, Wenqing Li, Linda Zuurbier, Milene C Silva, Maddalena Paganin, Julia Tritapoe, Julie A Hixon, André B Silveira, Bruno A Cardoso,[...]. Nat Genet 2011
263
36


PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability.
Ana Silva, J Andrés Yunes, Bruno A Cardoso, Leila R Martins, Patrícia Y Jotta, Miguel Abecasis, Alexandre E Nowill, Nick R Leslie, Angelo A Cardoso, Joao T Barata. J Clin Invest 2008
324
31

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.
Teresa Palomero, Maria Luisa Sulis, Maria Cortina, Pedro J Real, Kelly Barnes, Maria Ciofani, Esther Caparros, Jean Buteau, Kristy Brown, Sherrie L Perkins,[...]. Nat Med 2007
660
31

The genetics and molecular biology of T-ALL.
Tiziana Girardi, Carmen Vicente, Jan Cools, Kim De Keersmaecker. Blood 2017
140
31

CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia.
Sara González-García, Marina García-Peydró, Enrique Martín-Gayo, Esteban Ballestar, Manel Esteller, Rafael Bornstein, José Luis de la Pompa, Adolfo A Ferrando, María L Toribio. J Exp Med 2009
106
31

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.
Chen Shochat, Noa Tal, Obul R Bandapalli, Chiara Palmi, Ithamar Ganmore, Geertruy te Kronnie, Gunnar Cario, Giovanni Cazzaniga, Andreas E Kulozik, Martin Stanulla,[...]. J Exp Med 2011
234
31

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.
Jinghui Zhang, Li Ding, Linda Holmfeldt, Gang Wu, Sue L Heatley, Debbie Payne-Turner, John Easton, Xiang Chen, Jianmin Wang, Michael Rusch,[...]. Nature 2012
31

Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.
J J Peschon, P J Morrissey, K H Grabstein, F J Ramsdell, E Maraskovsky, B C Gliniak, L S Park, S F Ziegler, D E Williams, C B Ware,[...]. J Exp Med 1994
31

Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice.
B E Rich, J Campos-Torres, R I Tepper, R W Moreadith, P Leder. J Exp Med 1993
217
26

Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas.
Ninan Abraham, Melissa C Ma, Jonathan W Snow, Melissa Jill Miners, Brian G Herndier, Mark A Goldsmith. Oncogene 2005
38
26

IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Yunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, Andrew P Stubbs, Eric M Vroegindeweij, Willem K Smits, Ronald van Marion, Winand N M Dinjens, Martin Horstmann, Roland P Kuiper,[...]. PLoS Med 2016
62
26

CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
Diana Passaro, Marta Irigoyen, Claire Catherinet, Stéphanie Gachet, Cindy Da Costa De Jesus, Charlène Lasgi, Christine Tran Quang, Jacques Ghysdael. Cancer Cell 2015
106
26

The molecular basis of T cell acute lymphoblastic leukemia.
Pieter Van Vlierberghe, Adolfo Ferrando. J Clin Invest 2012
310
26

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.
K Canté-Barrett, J A P Spijkers-Hagelstein, J G C A M Buijs-Gladdines, J C M Uitdehaag, W K Smits, J van der Zwet, R C Buijsman, G J R Zaman, R Pieters, J P P Meijerink. Leukemia 2016
56
26

IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.
Mariana L Oliveira, Padma Akkapeddi, Daniel Ribeiro, Alice Melão, João T Barata. Adv Biol Regul 2019
38
26

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.
U von Freeden-Jeffry, P Vieira, L A Lucian, T McNeil, S E Burdach, R Murray. J Exp Med 1995
21

Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling.
C S Tremblay, F C Brown, M Collett, J Saw, S K Chiu, S E Sonderegger, S E Lucas, R Alserihi, N Chau, M L Toribio,[...]. Leukemia 2016
43
21

Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia.
Alejandro Gutierrez, Ruta Grebliunaite, Hui Feng, Elena Kozakewich, Shizhen Zhu, Feng Guo, Elspeth Payne, Marc Mansour, Suzanne E Dahlberg, Donna S Neuberg,[...]. J Exp Med 2011
84
21

Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.
Konstantinos J Mavrakis, Andrew L Wolfe, Elisa Oricchio, Teresa Palomero, Kim de Keersmaecker, Katherine McJunkin, Johannes Zuber, Taneisha James, Aly A Khan, Christina S Leslie,[...]. Nat Cell Biol 2010
250
21

CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.
Lauren A Pitt, Anastasia N Tikhonova, Hai Hu, Thomas Trimarchi, Bryan King, Yixiao Gong, Marta Sanchez-Martin, Aris Tsirigos, Dan R Littman, Adolfo A Ferrando,[...]. Cancer Cell 2015
163
21


High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
Alejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, Arkaitz Carracedo, Leonardo Salmena, Yebin Ahn, Suzanne Dahlberg, Donna Neuberg, Lisa A Moreau, Stuart S Winter,[...]. Blood 2009
318
21

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Shannon L Maude, Sibasish Dolai, Cristina Delgado-Martin, Tiffaney Vincent, Alissa Robbins, Arthavan Selvanathan, Theresa Ryan, Junior Hall, Andrew C Wood, Sarah K Tasian,[...]. Blood 2015
139
21

Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
A Puel, S F Ziegler, R H Buckley, W J Leonard. Nat Genet 1998
579
21

Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse.
Emmanuelle Clappier, Bastien Gerby, François Sigaux, Marc Delord, Farah Touzri, Lucie Hernandez, Paola Ballerini, André Baruchel, Françoise Pflumio, Jean Soulier. J Exp Med 2011
148
21


Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.
Francesca Chiarini, Cecilia Grimaldi, Francesca Ricci, Pier Luigi Tazzari, Camilla Evangelisti, Andrea Ognibene, Michela Battistelli, Elisabetta Falcieri, Fraia Melchionda, Andrea Pession,[...]. Cancer Res 2010
130
21

IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia.
Daniel Ribeiro, Alice Melão, João T Barata. Adv Biol Regul 2013
52
21

STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
Daniel Ribeiro, Alice Melão, Ruben van Boxtel, Cristina I Santos, Ana Silva, Milene C Silva, Bruno A Cardoso, Paul J Coffer, João T Barata. Blood Adv 2018
30
21

JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
C Delgado-Martin, L K Meyer, B J Huang, K A Shimano, M S Zinter, J V Nguyen, G A Smith, J Taunton, S S Winter, J R Roderick,[...]. Leukemia 2017
62
21

Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.
Deborah Bongiovanni, Valentina Saccomani, Erich Piovan. Int J Mol Sci 2017
40
21

Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.
M Noguchi, H Yi, H M Rosenblatt, A H Filipovich, S Adelstein, W S Modi, O W McBride, W J Leonard. Cell 1993
15

Cell biology of IL-7, a key lymphotrophin.
Qiong Jiang, Wen Qing Li, Francesca B Aiello, Renata Mazzucchelli, Benyam Asefa, Annette R Khaled, Scott K Durum. Cytokine Growth Factor Rev 2005
242
15

Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.
Francesca Chiarini, Federica Falà, Pier Luigi Tazzari, Francesca Ricci, Annalisa Astolfi, Andrea Pession, Pasqualepaolo Pagliaro, James A McCubrey, Alberto M Martelli. Cancer Res 2009
95
15

ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling.
Steven Goossens, Enrico Radaelli, Odile Blanchet, Kaat Durinck, Joni Van der Meulen, Sofie Peirs, Tom Taghon, Cedric S Tremblay, Magdaline Costa, Morvarid Farhang Ghahremani,[...]. Nat Commun 2015
60
15

Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia.
T Bains, M C Heinrich, M M Loriaux, C Beadling, D Nelson, A Warrick, T L Neff, J W Tyner, J Dunlap, C L Corless,[...]. Leukemia 2012
50
15

Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL.
Samuel Gusscott, Florian Kuchenbauer, R Keith Humphries, Andrew P Weng. Leuk Res 2012
35
15


Interleukin-7 receptor expression: intelligent design.
Renata Mazzucchelli, Scott K Durum. Nat Rev Immunol 2007
441
15


Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors.
Antonis Dagklis, Sofie Demeyer, Jolien De Bie, Enrico Radaelli, Daphnie Pauwels, Sandrine Degryse, Olga Gielen, Carmen Vicente, Roel Vandepoel, Ellen Geerdens,[...]. Blood 2016
28
15

K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors.
Thomas Kindler, Melanie G Cornejo, Claudia Scholl, Jianing Liu, Dena S Leeman, J Erika Haydu, Stefan Fröhling, Benjamin H Lee, D Gary Gilliland. Blood 2008
67
15

High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling.
Hind Medyouf, Samuel Gusscott, Hongfang Wang, Jen-Chieh Tseng, Carol Wai, Oksana Nemirovsky, Andreas Trumpp, Francoise Pflumio, Joan Carboni, Marco Gottardis,[...]. J Exp Med 2011
121
15

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
Jennifer O'Neil, Jonathan Grim, Peter Strack, Sudhir Rao, Deanne Tibbitts, Christopher Winter, James Hardwick, Markus Welcker, Jules P Meijerink, Rob Pieters,[...]. J Exp Med 2007
494
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.